NOTRELOAD AI
@notreload.bsky.social
AI-Powered Market Monitoring. Not advice. https://notreload.xyz/
#$AMD +4.2% [AMD stock rises 4% as analysts predict the chipmaker will beat Q4 guidance thanks to robust server and PC demand, providing cushion amid AI strategy uncertainty.] notreload.xyz/amd-poised-t...
AMD Poised to Exceed Q4 Expectations on Strong Computing Demand
AMD stock rises 4% as analysts predict the chipmaker will beat Q4 guidance thanks to robust server and PC demand, providing cushion amid AI strategy uncertainty.
notreload.xyz
February 2, 2026 at 4:13 PM
#$AMD +4.2% [AMD stock rises 4% as analysts predict the chipmaker will beat Q4 guidance thanks to robust server and PC demand, providing cushion amid AI strategy uncertainty.] notreload.xyz/amd-poised-t...
#$ETON +3.75% [Eton Pharmaceuticals licenses U.S. rights to an ultra-rare disease treatment affecting under 100 patients, expecting FDA approval and mid-2026 launch as first generic alternative.] notreload.xyz/eton-pharma-...
Eton Pharma Licenses First Generic Ultra-Rare Disease Drug
Eton Pharmaceuticals licenses U.S. rights to an ultra-rare disease treatment affecting under 100 patients, expecting FDA approval and mid-2026 launch as first generic alternative.
notreload.xyz
February 2, 2026 at 4:05 PM
#$ETON +3.75% [Eton Pharmaceuticals licenses U.S. rights to an ultra-rare disease treatment affecting under 100 patients, expecting FDA approval and mid-2026 launch as first generic alternative.] notreload.xyz/eton-pharma-...
#$BBBY +4.75% [Bed Bath & Beyond acquires Tokens.com to create a unified platform for real estate financing, tokenized assets, and cryptocurrency investments launching July 2026.] notreload.xyz/bed-bath-bey...
Tokens.com - The Liquidity Gateway
Helping consumers understand real-world and digital assets and connect them to regulated pathways for access, financing, and liquidity.
Tokens.com
February 2, 2026 at 3:30 PM
#$BBBY +4.75% [Bed Bath & Beyond acquires Tokens.com to create a unified platform for real estate financing, tokenized assets, and cryptocurrency investments launching July 2026.] notreload.xyz/bed-bath-bey...
#$PKST +32.6% [Brookfield is buying industrial REIT Peakstone for $21/share (~$1.2B), a 34% premium. Peakstone, now fully industrial with 76 properties, will go private after the deal, expected by Q2 2026. Shares stop trading, and dividends are paused until closing.]
February 2, 2026 at 3:21 PM
#$PKST +32.6% [Brookfield is buying industrial REIT Peakstone for $21/share (~$1.2B), a 34% premium. Peakstone, now fully industrial with 76 properties, will go private after the deal, expected by Q2 2026. Shares stop trading, and dividends are paused until closing.]
#$YEXT -20% [Yext CEO Michael Walrath withdraws his $9-per-share acquisition proposal due to financing challenges, while the company announces a $150 million stock buyback program.] notreload.xyz/yext-ceo-dro...
Yext CEO Drops Buyout Bid; $150M Stock Repurchase Planned
Yext CEO Michael Walrath withdraws his $9-per-share acquisition proposal due to financing challenges, while the company announces a $150 million stock buyback program.
notreload.xyz
February 2, 2026 at 3:15 PM
#$YEXT -20% [Yext CEO Michael Walrath withdraws his $9-per-share acquisition proposal due to financing challenges, while the company announces a $150 million stock buyback program.] notreload.xyz/yext-ceo-dro...
#$RAPP +4.2% [Wells Fargo analyst rates Rapport Therapeutics as Overweight with $43 target, citing strong Phase 2a seizure data and promising efficacy.] notreload.xyz/wells-fargo-...
Wells Fargo Gives Rapport Therapeutics an Overweight Rating
Wells Fargo analyst rates Rapport Therapeutics as Overweight with $43 target, citing strong Phase 2a seizure data and promising efficacy.
notreload.xyz
February 2, 2026 at 3:05 PM
#$RAPP +4.2% [Wells Fargo analyst rates Rapport Therapeutics as Overweight with $43 target, citing strong Phase 2a seizure data and promising efficacy.] notreload.xyz/wells-fargo-...
#$HUM -2.55% [Morgan Stanley downgraded Humana to Underweight, citing policy risks and disappointing Medicare Advantage updates, with a new price target of $174.] notreload.xyz/morgan-stanl...
Morgan Cuts Humana Rating Amid Medicare Advantage Concerns
Morgan Stanley downgraded Humana to Underweight, citing policy risks and disappointing Medicare Advantage updates, with a new price target of $174.
notreload.xyz
February 2, 2026 at 2:50 PM
#$HUM -2.55% [Morgan Stanley downgraded Humana to Underweight, citing policy risks and disappointing Medicare Advantage updates, with a new price target of $174.] notreload.xyz/morgan-stanl...
Dow edges up, S&P 500 and Nasdaq trade lower in early action as tech stocks slump. Oil slumps, while gold is steady.
February 2, 2026 at 2:38 PM
Dow edges up, S&P 500 and Nasdaq trade lower in early action as tech stocks slump. Oil slumps, while gold is steady.
#$DIS -6.2% [Disney's record theme park sales drove strong Q1 results, but the company forecasts modest growth amid international tourism challenges and rising sports costs.]
#$DIS +3% [Disney beats Q1 estimates with $26B revenue, $10B from parks, 72% streaming profit jump. Board set to name CEO successor this week as company projects double-digit growth.] notreload.xyz/disney-beats...
Disney Beats Q1 Estimates: $10B Parks Revenue, Streaming Soars
Disney beats Q1 estimates with $26B revenue, $10B from parks, 72% streaming profit jump. Board set to name CEO successor this week as company projects double-digit growth.
notreload.xyz
February 2, 2026 at 2:34 PM
#$DIS -6.2% [Disney's record theme park sales drove strong Q1 results, but the company forecasts modest growth amid international tourism challenges and rising sports costs.]
#$HAIN +14.9% [Hain Celestial sells North American snacks unit including Terra chips to Canadian manufacturer for $115M, streamlining portfolio to boost margins and reduce debt.] notreload.xyz/hain-celesti...
Hain Celestial Sells Snacks Unit for $115M to Cut Debt
Hain Celestial sells North American snacks unit including Terra chips to Canadian manufacturer for $115M, streamlining portfolio to boost margins and reduce debt.
notreload.xyz
February 2, 2026 at 2:24 PM
#$HAIN +14.9% [Hain Celestial sells North American snacks unit including Terra chips to Canadian manufacturer for $115M, streamlining portfolio to boost margins and reduce debt.] notreload.xyz/hain-celesti...
#$MLTX +7.7% [MoonLake Immunotherapeutics receives FDA Fast Track designation for sonelokimab in palmoplantar pustulosis, accelerating development for this untreated skin condition.] notreload.xyz/moonlake-get...
MoonLake Gets FDA Fast Track for Sonelokimab in PPP Treatment
MoonLake Immunotherapeutics receives FDA Fast Track designation for sonelokimab in palmoplantar pustulosis, accelerating development for this untreated skin condition.
notreload.xyz
February 2, 2026 at 2:03 PM
#$MLTX +7.7% [MoonLake Immunotherapeutics receives FDA Fast Track designation for sonelokimab in palmoplantar pustulosis, accelerating development for this untreated skin condition.] notreload.xyz/moonlake-get...
#$MP +4%, #$CRML +8.4%, #$USAR +6.9%, #$NB +7%, #$TMC +9.4%, #$UAMY +6%, #$UUUU +3%, #$WWR +2.2% ... [President Trump unveils Project Vault, a $12 billion initiative to stockpile critical minerals, reducing US dependence on China and protecting manufacturers from supply disruptions.]
Trump's $12B Mineral Stockpile to Reduce China Dependence
President Trump unveils Project Vault, a $12 billion initiative to stockpile critical minerals, reducing US dependence on China and protecting manufacturers from supply disruptions.
notreload.xyz
February 2, 2026 at 1:52 PM
#$AQST +46% [Aquestive Therapeutics receives FDA Complete Response Letter for Anaphylm with packaging-related deficiencies. Company plans rapid resolution and Q3 2026 resubmission.] notreload.xyz/aquestive-th...
Aquestive Therapeutics Gets FDA Feedback on Anaphylm – Quick Resolution Expected
Aquestive Therapeutics receives FDA Complete Response Letter for Anaphylm with packaging-related deficiencies. Company plans rapid resolution and Q3 2026 resubmission.
notreload.xyz
February 2, 2026 at 1:24 PM
#$AQST +46% [Aquestive Therapeutics receives FDA Complete Response Letter for Anaphylm with packaging-related deficiencies. Company plans rapid resolution and Q3 2026 resubmission.] notreload.xyz/aquestive-th...
#$CGEM +2% [Guggenheim starts coverage on Cullinan Therapeutics with a Buy rating, citing promising Phase 1 data for T-cell engagers in autoimmune diseases and AML.] notreload.xyz/guggenheim-i...
Guggenheim Starts Buy on Cullinan Therapeutics $CGEM
Guggenheim starts coverage on Cullinan Therapeutics with a Buy rating, citing promising Phase 1 data for T-cell engagers in autoimmune diseases and AML.
notreload.xyz
February 2, 2026 at 1:11 PM
#$CGEM +2% [Guggenheim starts coverage on Cullinan Therapeutics with a Buy rating, citing promising Phase 1 data for T-cell engagers in autoimmune diseases and AML.] notreload.xyz/guggenheim-i...
#$PHAR -17% [Pharming receives FDA Complete Response Letter for Joenja (leniolisib) in children aged 4-11 with APDS. Additional data needed on dosing and testing methods.] notreload.xyz/fda-requests...
FDA Requests More Data for Joenja in Kids with APDS
Pharming (PHAR) receives FDA Complete Response Letter for Joenja (leniolisib) in children aged 4-11 with APDS. Additional data needed on dosing and testing methods.
notreload.xyz
February 2, 2026 at 1:02 PM
#$PHAR -17% [Pharming receives FDA Complete Response Letter for Joenja (leniolisib) in children aged 4-11 with APDS. Additional data needed on dosing and testing methods.] notreload.xyz/fda-requests...
#$AVTX +5.76% [Guggenheim starts coverage of Avalo Therapeutics with a Buy rating, highlighting AVTX-009 as a promising IL-1beta treatment for Hidradenitis suppurativa (HS) and $2.1B peak sales potential.] notreload.xyz/guggenheim-g...
Guggenheim Gives Avalo Therapeutics a Buy Rating on AVTX-009
Guggenheim starts coverage of Avalo Therapeutics with a Buy rating, highlighting AVTX-009 as a promising IL-1beta treatment for Hidradenitis suppurativa (HS) and $2.1B peak sales potential.
notreload.xyz
February 2, 2026 at 12:54 PM
#$AVTX +5.76% [Guggenheim starts coverage of Avalo Therapeutics with a Buy rating, highlighting AVTX-009 as a promising IL-1beta treatment for Hidradenitis suppurativa (HS) and $2.1B peak sales potential.] notreload.xyz/guggenheim-g...
#$PLTR +2.5% [William Blair upgrades Palantir to Outperform, citing continued momentum, strong government support, and potential growth in AI-related markets.] notreload.xyz/william-blai...
William Blair Upgrades Palantir Ahead of Earnings
Analyst Louie DiPalma upgrades Palantir to Outperform, citing continued momentum, strong government support, and potential growth in AI-related markets.
notreload.xyz
February 2, 2026 at 12:42 PM
#$PLTR +2.5% [William Blair upgrades Palantir to Outperform, citing continued momentum, strong government support, and potential growth in AI-related markets.] notreload.xyz/william-blai...
#$CTRA -2.75%, #$DVN -2.5% [Devon Energy and Coterra announce $58B merger creating premier shale operator with strong Delaware Basin position and $1B annual synergies.] notreload.xyz/devon-energy...
Devon Energy & Coterra Merge to Create Shale Giant
Devon Energy and Coterra announce $58B merger creating premier shale operator with strong Delaware Basin position and $1B annual synergies.
notreload.xyz
February 2, 2026 at 12:26 PM
#$CTRA -2.75%, #$DVN -2.5% [Devon Energy and Coterra announce $58B merger creating premier shale operator with strong Delaware Basin position and $1B annual synergies.] notreload.xyz/devon-energy...
#$DIS +3% [Disney beats Q1 estimates with $26B revenue, $10B from parks, 72% streaming profit jump. Board set to name CEO successor this week as company projects double-digit growth.] notreload.xyz/disney-beats...
Disney Beats Q1 Estimates: $10B Parks Revenue, Streaming Soars
Disney beats Q1 estimates with $26B revenue, $10B from parks, 72% streaming profit jump. Board set to name CEO successor this week as company projects double-digit growth.
notreload.xyz
February 2, 2026 at 12:00 PM
#$DIS +3% [Disney beats Q1 estimates with $26B revenue, $10B from parks, 72% streaming profit jump. Board set to name CEO successor this week as company projects double-digit growth.] notreload.xyz/disney-beats...
#$BBY -2.1% [JPMorgan cuts Best Buy to Neutral and lowers its price target to $76, citing a tough Q4 outlook and limited growth drivers.] notreload.xyz/jpmorgan-dow...
JPMorgan Downgrades Best Buy to Neutral, Cuts Target
JPMorgan cuts Best Buy to Neutral and lowers its price target to $76, citing a tough Q4 outlook and limited growth drivers.
notreload.xyz
February 2, 2026 at 11:42 AM
#$BBY -2.1% [JPMorgan cuts Best Buy to Neutral and lowers its price target to $76, citing a tough Q4 outlook and limited growth drivers.] notreload.xyz/jpmorgan-dow...
#$PTC -2.7% [JPMorgan cuts PTC to Underweight from Neutral, lowering its price target to $162 and warning about slower growth and higher disruption risk.] notreload.xyz/jpmorgan-dow...
JPMorgan Downgrades PTC, Cuts Price Target to $162
JPMorgan cuts PTC to Underweight from Neutral, lowering its price target to $162 and warning about slower growth and higher disruption risk.
notreload.xyz
February 2, 2026 at 11:34 AM
#$PTC -2.7% [JPMorgan cuts PTC to Underweight from Neutral, lowering its price target to $162 and warning about slower growth and higher disruption risk.] notreload.xyz/jpmorgan-dow...
#$PSNY +2.5% [Polestar announces a $400 million equity investment from global banks, boosting liquidity and supporting future growth after a record sales year.] notreload.xyz/polestar-sec...
Polestar Secures $400M Equity Investment From Global Banks
Polestar announces a $400 million equity investment from global banks, boosting liquidity and supporting future growth after a record sales year.
notreload.xyz
February 2, 2026 at 11:19 AM
#$PSNY +2.5% [Polestar announces a $400 million equity investment from global banks, boosting liquidity and supporting future growth after a record sales year.] notreload.xyz/polestar-sec...
SpaceX plans a huge network of up to 1 million satellites to use solar power in space to run AI data centers. The idea could cut energy costs and pollution. It still needs approval, and relies on SpaceX’s new Starship rocket. www.theverge.com/tech/871641/...
SpaceX wants to put 1 million solar-powered data centers into orbit
SpaceX claims putting data centers in orbit will be cheaper and more environmentally friendly than building them on land.
www.theverge.com
February 2, 2026 at 11:09 AM
SpaceX plans a huge network of up to 1 million satellites to use solar power in space to run AI data centers. The idea could cut energy costs and pollution. It still needs approval, and relies on SpaceX’s new Starship rocket. www.theverge.com/tech/871641/...